# IN8BIO, Inc.: Form 8-K, filed Mar 12, 2026

- Company: [IN8BIO, Inc.](/companies/inab.md) (CIK 1740279)
- Form: 8-K
- Filed: 2026-03-12
- Accepted by EDGAR: Mar 12, 2026, 16:10 ET
- Period: 2026-03-12
- Accession: 0001193125-26-104144
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1740279/000119312526104144/inab-20260312.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1740279/000119312526104144/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1740279/000119312526104144/inab-20260312.htm

Filed Mar 12, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-104144. Last ingested by Listed: Nov 5, 2026, 17:49 ET. No prices; not investment advice.
